ImmunoClin Corp (OTC Pink - Limited Information:IMCL)

1.10
Delayed Data
As of Jun 26
 0.00 / 0.00%
Today’s Change
1.10
Today|||52-Week Range
5.60
-78.00%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Biotechnology
MARKET CAP
$31.7M

Company Description

Immunoclin Corp., engages in immunology research and development. It operates through its subsidiary, Immunoclin Limited, which provides specialized, commercially-focused immunology consulting, testing and assessment, in the context of research and development clinical services. Its products include: MIRA™, GARD™, PRIMALEUKIN™, DACTELLIGENCE™, and GastroWellBeing™. The company was founded on February 8, 2011 and is headquartered in Washington, DC.

Contact Information

Immunoclin Corp.
1800 Wyoming Avenue, NW
Washington District Of Columbia 20009
P:(888) 267-1175
Investor Relations:

Employees

Shareholders

Individual stakeholders100.59%
Mutual fund holders--
Other institutional--

Top Executives

Dorothy H. BrayPresident, Chief Executive Officer & Director
Chad S. JohnsonCOO, Secretary, Director & General Counsel
James Scott MunroCFO, Treasurer & Principal Accounting Officer
Khadija BenlhassanDirector & Chief Scientific Officer

To view my watchlist

Not a member yet?

Sign up now for a free account